News

Soleno Therapeutics to Participate in the ROTH Battle of NASH Thrones Spring Investor Conference

March 25, 2019

REDWOOD CITY, Calif. , March 25, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results

March 18, 2019

REDWOOD CITY, Calif. , March 18, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Announces Positive Outcome from Planned Data Safety Monitoring Board Review of Phase III DESTINY PWS Clinical Trial of DCCR in Prader-Willi Syndrome

March 14, 2019

REDWOOD CITY, Calif. --(BUSINESS WIRE)--Mar. 14, 2019-- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage ...

Read More
Soleno – Home